Report #2840553

Overview

Sex

Male

Age

60 yrs

State

WI

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Inappropriate schedule/had his second dose administered approximately 8 months later; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix on 21 Apr 2016, intramuscular). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: Inappropriate schedule/had his second dose administered approximately 8 months later). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK Receipt Date: 01-MAY-2025 The patient had his first dose of Shingrix administered 21 APR 2016 (unknown site of administration.) Consumer stated he had his second dose administered approximately 8 months later (exact date unknown) which led to Drug dose administration interval too long. No further information was provided/obtained.